Stocktoria
60 DEGREES PHARMACEUTICALS, INC. SXTP
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-07-12
60 DEGREES PHARMACEUTICALS, INC. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $1.0M | $607,574 | $253,573 | $223,208 |
| Gross profit | $223,776 | $222,809 | -$220,977 | -$209,162 |
| R&D expense | $2.1M | $5.0M | $691,770 | $525,563 |
| Operating income | -$7.8M | -$9.7M | -$5.2M | -$1.8M |
| Interest expense | — | — | $2.3M | $4.0M |
| Income tax | $0 | $0 | $250 | $500 |
| Net income | -$7.4M | -$7.9M | -$3.8M | -$6.2M |
| EPS (diluted) | $-11.73 | $-74.17 | $-59.18 | $-2.61 |
| Operating cash flow | -$6.8M | -$5.6M | -$4.5M | -$1.0M |
| Free cash flow | -$7.0M | -$5.8M | -$4.6M | — |
| Cash & equivalents | $1.5M | $1.7M | $2.1M | — |
| Inventory | $656,924 | $442,764 | $466,169 | $518,578 |
| Total assets | $5.4M | $5.8M | $7.8M | $1.3M |
| Total liabilities | $2.0M | $1.8M | $3.0M | $25.4M |
| Shareholders' equity | $3.5M | $4.0M | $4.9M | -$24.1M |
Growth · year-over-year · Revenue CAGR 65.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +65.5% | +139.6% | +13.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.